PhageNova Bio PhageNova Bio (formerly AAVP Biosystems) is a company specializing in cancer treatment. | ![]() ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. | ![]() PharmaEssentia PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases. | ||
Founding Date | Founding Date N/A | Founding Date 1991 | Founding Date 1994 | Founding Date 2003 |
Type | Type Private | Type Subsidiary | Type Public | Type Public |
Tags | ||||
Locations | Locations Summit, US HQ | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more | Locations Alameda, US HQ | Locations Taipei, TW HQ Shinjuku City, JP Burlington, US |
Employees | Employees 8 | Employees 1381% increase | Employees 1,14712% decrease | Employees 4897% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $118.8m (FY, 2015) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) NT$15.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $2.1m (FY, 2015) | Cost of goods $83.7m (FY, 2025) | Cost of goods NT$1.3b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $116.7m (FY, 2015) | Gross profit $2.2b (FY, 2025) | Gross profit NT$14.4b (FY, 2025) |
Net income | Net income N/A | Net income ($231.2m) (FY, 2015) | Net income $782.6m (FY, 2025) | Net income NT$5b (FY, 2025) |

ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers.
View company
Exelixis is an oncology company that develops cancer treatments.
View company
PharmaEssentia (藥華醫藥股份有限公司) is a biotech company focused on the areas of hematology, oncology, dermatology, and infectious diseases.
View company